81_FR_38305 81 FR 38192 - National Cancer Institute; Notice of Closed Meetings

81 FR 38192 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 113 (June 13, 2016)

Page Range38192-38193
FR Document2016-13930

Federal Register, Volume 81 Issue 113 (Monday, June 13, 2016)
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Pages 38192-38193]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-13930]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Diagnostics, Prognostics and Detection.
    Date: June 15, 2016.
    Time: 1:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W032/034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Gerard Lacourciere, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W248, Rockville, MD 20892-9750, 240-276-5457, 
gerard.lacourciere@mail.nih.gov.


[[Page 38193]]


    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Software for Measuring Environmental Effects on Cancer.
    Date: June 30, 2016.
    Time: 1:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W030 Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Gerard Lacourciere, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W248, Rockville, MD 20892-9750, 240-276-5457, 
gerard.lacourciere@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 8, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13930 Filed 6-10-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                38192                                      Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices

                                                assigned OMB control number 0990–                                           current questions about grantee use of                          media questions is necessary because
                                                0275, which expires on 08/31/2016.                                          social media. The modified social media                         social media platforms, such as
                                                Prior to submitting the ICR to OMB, OS                                      questions in PDS will be more                                   Facebook, Twitter, and blogs, are
                                                seeks comments from the public                                              applicable to OMH grantees, more easily                         becoming increasingly utilized by
                                                regarding the burden estimate, below, or                                    understood, and collect more accurate                           grantees for their usability, free access,
                                                any other aspect of the ICR.                                                quantitative metrics. Grantee data                              and ability to reach a larger audience.
                                                DATES: Comments on the ICR must be                                          collection via the UDS (original data                           The revised questions will lead to
                                                received on or before August 12, 2016.                                      collection system) was first approved by                        increased data collection completeness
                                                ADDRESSES: Submit your comments to
                                                                                                                            OMB on June 7, 2004 (OMB No. 0990–                              and quality.
                                                Information.CollectionClearance@                                            275). OMB approval was also received                               Likely Respondents: Respondents for
                                                hhs.gov or by calling (202) 690–6162.                                       for modifications to the UDS (August                            this data collection include the project
                                                                                                                            23, 2007), which upgraded the data                              directors for OMH-funded projects and/
                                                FOR FURTHER INFORMATION CONTACT:                                            collection tool from the UDS to the PDS
                                                Information Collection Clearance staff,                                                                                                     or the date entry persons for each OMH-
                                                                                                                            (August 31, 2010). A 3-year extension                           funded project. Affected public includes
                                                Information.CollectionClearance@                                            without change of the approved PDS
                                                hhs.gov or (202) 690–6162.                                                                                                                  non-profit institutions, State, Local, or
                                                                                                                            collection was approved August 1, 2013.
                                                SUPPLEMENTARY INFORMATION: When                                                                                                             Tribal Governments.
                                                                                                                            Clearance is due to expire on August 31,
                                                submitting comments or requesting                                           2016.                                                              Burden Statement: Burden in this
                                                information, please include the                                                Need and Proposed Use of the                                 context means the time expended by
                                                document identifier HHS–OS–0990–                                            Information: The clearance is needed to                         persons to generate, maintain, retain,
                                                0275–60D for reference.                                                     continue data collection using the PDS,                         disclose or provide the information
                                                  Information Collection Request Title:                                     a system that enables OMH to comply                             requested. This includes the time
                                                Performance Data System (PDS) (OMB                                          with Federal reporting requirements and                         needed to review instructions, to
                                                No. 0990–0275).                                                             monitor and evaluate performance by                             develop, acquire, install and utilize
                                                  Abstract: This request for clearance is                                   enabling the efficient collection of                            technology and systems for the purpose
                                                to revise data collection activities and                                    performance-oriented data tied to OMH-                          of collecting, validating and verifying
                                                extend by three (3) years a currently                                       wide performance reporting needs. The                           information, processing and
                                                approved collection using the OMB                                           ability to monitor and evaluate                                 maintaining information, and disclosing
                                                approved Performance Data System                                            performance in this manner, and to                              and providing information, to train
                                                (PDS) (OMB No. 0990–0275), the tool                                         work towards continuous program                                 personnel and to be able to respond to
                                                used by the Office of Minority Health                                       improvement are basic functions that                            a collection of information, to search
                                                (OMH) to collect program management                                         OMH must be able to accomplish in                               data sources, to complete and review
                                                and performance data for all OMH-                                           order to carry out its mandate with the                         the collection of information, and to
                                                funded projects. The revised data                                           most effective and appropriate use of                           transmit or otherwise disclose the
                                                collection activities pertain only to                                       resources. The revision of the social                           information.

                                                                                                                  TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
                                                                                                                                                                                                               Average
                                                                                                                                                                                           Number of
                                                                                                                                                                          Number of                             burden       Total burden
                                                                                                  Form name                                                                              responses per
                                                                                                                                                                         respondents                         per response       hours
                                                                                                                                                                                           respondent         (in hours)

                                                PDS ..................................................................................................................             100                 4               1.5            600

                                                      Total ..........................................................................................................             100                 4               1.5            600



                                                  OS specifically requests comments on                                      DEPARTMENT OF HEALTH AND                                        proposals, the disclosure of which
                                                (1) the necessity and utility of the                                        HUMAN SERVICES                                                  would constitute a clearly unwarranted
                                                proposed information collection for the                                                                                                     invasion of personal privacy.
                                                proper performance of the agency’s                                          National Institutes of Health
                                                                                                                                                                                              Name of Committee: National Cancer
                                                functions, (2) the accuracy of the                                                                                                          Institute Special Emphasis Panel; Cancer
                                                                                                                            National Cancer Institute; Notice of
                                                estimated burden, (3) ways to enhance                                                                                                       Diagnostics, Prognostics and Detection.
                                                                                                                            Closed Meetings
                                                the quality, utility, and clarity of the                                                                                                      Date: June 15, 2016.
                                                information to be collected, and (4) the                                      Pursuant to section 10(d) of the                                Time: 1:30 p.m. to 5:00 p.m.
                                                use of automated collection techniques                                      Federal Advisory Committee Act, as                                Agenda: To review and evaluate contract
                                                or other forms of information                                               amended (5 U.S.C. App.), notice is                              proposals.
                                                technology to minimize the information                                      hereby given of the following meetings.                           Place: National Cancer Institute Shady
                                                collection burden.                                                                                                                          Grove, 9609 Medical Center Drive, Room
                                                                                                                              The meetings will be closed to the                            4W032/034, Rockville, MD 20850,
                                                Terry S. Clark,                                                             public in accordance with the                                   (Telephone Conference Call).
                                                                                                                            provisions set forth in sections
srobinson on DSK5SPTVN1PROD with NOTICES




                                                Asst Information Collection Clearance                                                                                                         Contact Person: Gerard Lacourciere, Ph.D.,
                                                Officer.
                                                                                                                            552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                      Scientific Review Officer, Research
                                                                                                                            as amended. The contract proposals and                          Technology and Contract Review Branch,
                                                [FR Doc. 2016–13833 Filed 6–10–16; 8:45 am]
                                                                                                                            the discussions could disclose                                  Division of Extramural Activities, National
                                                BILLING CODE 4150–29–P                                                      confidential trade secrets or commercial                        Cancer Institute, 9609 Medical Center Drive,
                                                                                                                            property such as patentable material,                           Room 7W248, Rockville, MD 20892–9750,
                                                                                                                            and personal information concerning                             240–276–5457, gerard.lacourciere@
                                                                                                                            individuals associated with the contract                        mail.nih.gov.



                                           VerDate Sep<11>2014         20:48 Jun 10, 2016         Jkt 238001       PO 00000        Frm 00066       Fmt 4703       Sfmt 4703   E:\FR\FM\13JNN1.SGM   13JNN1


                                                                               Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices                                             38193

                                                  This notice is being published less than 15           Research (SBIR) and Small Business                     or traditional modes of research funding
                                                days prior to the meeting due to the timing             Technology Transfer (STTR) funding.                    (e.g. small business grants).
                                                limitations imposed by the review and                   Each Challenge winner will receive                        What does it take to participate in the
                                                funding cycle.                                                                                                 Challenge? The team or an individual
                                                                                                        $10,000. The Challenge total purse is up
                                                  Name of Committee: National Cancer                    to $100,000.                                           must have a research idea that could
                                                Institute Special Emphasis Panel, Software                                                                     further the understanding of SUD and is
                                                for Measuring Environmental Effects on                  DATES: The Challenge begins June 13,
                                                                                                        2016.                                                  intended to be the basis of the
                                                Cancer.
                                                  Date: June 30, 2016.                                     Submission Period: June 13, 2016 to                 development of a new and potentially
                                                  Time: 1:30 p.m. to 5:00 p.m.                          September 16, 2016, 11:59 p.m., ET.                    successful startup. The research ‘‘idea’’
                                                  Agenda: To review and evaluate contract                  Judging Period: September 19, 2016 to               is the product that your future startup
                                                proposals.                                              October 21, 2016.                                      will offer. Here, the term startup
                                                  Place: National Cancer Institute Shady                   Winners Announced: October 24,                      ‘‘product’’ is used in its broadest
                                                Grove, 9609 Medical Center Drive, Room                  2016.                                                  definition. Product is any source of
                                                4W030 Rockville, MD 20850, (Telephone                                                                          value for the people who become
                                                Conference Call).                                       FOR FURTHER INFORMATION CONTACT: Irina
                                                                                                        Sazonova, Ph.D., M.Sc., Health Scientist               customers. Services, subscriptions,
                                                  Contact Person: Gerard Lacourciere, Ph.D.,
                                                Scientific Review Officer, Research                     Administrator, Office of Translational                 software as a service (SaaS), physical/
                                                Technology and Contract Review Branch,                  Initiatives and Program Innovations                    tangible products, aggregations, etc.
                                                Division of Extramural Activities, National                                                                    could all provide value and thus be
                                                                                                        (OTIPI), NIDA Challenge Administrator,
                                                Cancer Institute, 9609 Medical Center Drive,                                                                   considered startup products. The
                                                                                                        National Institute on Drug Abuse
                                                Room 7W248, Rockville, MD 20892–9750,                                                                          startup product could be the result of
                                                                                                        (NIDA), 6001 Executive Blvd. Room
                                                240–276–5457, gerard.lacourciere@                                                                              novel scientific discoveries, repurposing
                                                mail.nih.gov.                                           4206, MSC 9555 Bethesda, MD 20892–
                                                                                                                                                               an existing technology for a new use,
                                                                                                        9555. Phone: (301) 827–9564, Email:
                                                (Catalogue of Federal Domestic Assistance                                                                      extending a research observation into a
                                                Program Nos. 93.392, Cancer Construction;               irina.sazonova@nih.gov.
                                                                                                                                                               different area, devising a new business
                                                93.393, Cancer Cause and Prevention                     SUPPLEMENTARY INFORMATION: The                         model or distribution/delivery channel
                                                Research; 93.394, Cancer Detection and                  Institute’s Statutory Authority to                     that unlocks value currently concealed,
                                                Diagnosis Research; 93.395, Cancer                      Conduct the Challenge. NIDA is
                                                Treatment Research; 93.396, Cancer Biology
                                                                                                                                                               or simply bringing a product or service
                                                                                                        conducting this Challenge under the                    to previously underserved set of
                                                Research; 93.397, Cancer Centers Support;               America Creating Opportunities to
                                                93.398, Cancer Research Manpower; 93.399,                                                                      customers. The Founder (the teams or
                                                Cancer Control, National Institutes of Health,
                                                                                                        Meaningfully Promote Excellence in                     an individual) must demonstrate
                                                HHS)                                                    Technology, Education, and Science                     through the Submission the passion,
                                                                                                        (COMPETES) Reauthorization Act of                      drive, discipline, ability to work
                                                  Dated: June 8, 2016.                                  2010, 15 U.S.C. 3719. The general
                                                Melanie J. Gray,
                                                                                                                                                               collaboratively and willingness to push
                                                                                                        purpose of NIDA is to conduct and                      forward under conditions of extreme
                                                Program Analyst, Office of Federal Advisory             support biomedical and behavioral                      business uncertainty.
                                                Committee Policy.                                       research, health-services research,                       The winners of this Challenge are
                                                [FR Doc. 2016–13930 Filed 6–10–16; 8:45 am]             research training, and health-                         encouraged to use the prize funds to
                                                BILLING CODE 4140–01–P                                  information dissemination with respect                 develop a minimum viable proof (MVP)
                                                                                                        to the prevention of drug abuse and the                as quickly as possible and to obtain
                                                                                                        treatment of drug abusers. This                        customer feedback to discover if MVP
                                                DEPARTMENT OF HEALTH AND                                Challenge is consistent with and                       meets the customer needs. If the product
                                                HUMAN SERVICES                                          advances the mission of NIDA as                        prototype is successfully validated,
                                                                                                        described in 42 U.S.C. 285o in that it                 winners are encouraged to create or
                                                National Institutes of Health
                                                                                                        supports new and potential biotech                     further advance their biotech startup no
                                                Announcement of Requirements and                        start-ups in the development of research               later than 6 months after the prize is
                                                Registration for ‘‘$100,000 for Start a                 ideas that would further an                            awarded. Post Challenge, as with all
                                                SUD Startup’’ Challenge                                 understanding of neurobiology as it                    other NIH grant applicants, NIDA staff
                                                                                                        relates to SUD.                                        will provide dedicated assistance and
                                                SUMMARY:    The National Institute on                      Subject of Challenge. NIDA is excited               guidance about the NIH grant
                                                Drug Abuse (NIDA), one of the                           to announce the first competition for                  submission process, including
                                                components of the National Institutes of                biomedical scientists with the goal to                 submissions for the SBIR/STTR grants.
                                                Health (NIH), announces the ‘‘$100,000                  support research ideas that would                         The research idea must be broad
                                                for Start a SUD Startup’’ Challenge. The                further an understanding of                            enough to address multiple conditions,
                                                Challenge goal is to support research                   neurobiology as it relates to SUD and                  diseases, or indications consistent with
                                                ideas that would further an                             that are intended to be the basis for the              SUD or be specific for prevention and
                                                understanding of neurobiology as it                     development of a new and potentially                   treatments of SUD. For example, if your
                                                relates to Substance Use Disorders                      successful start-up. NIDA hopes that                   idea can only work for cancer or
                                                (SUD) and that are intended to be the                   participation in the contest will enable               diabetes, entering this Challenge is not
                                                basis for the development of a new and                  scientists to test whether their research              appropriate. However, if the plan is to
                                                potentially successful start-up. NIDA                   ideas can be fostered into a biotech                   test an idea for a research tool that
                                                hopes that participation in the contest                 startup. In 2016, NIDA will award up to                would further an understanding of
                                                will enable scientists to test the                      $100,000 in prizes to up to 10 winners                 neurobiology or epigenetics relevant to
srobinson on DSK5SPTVN1PROD with NOTICES




                                                hypothesis that their research idea can                 of the contest, $10,000 each.                          SUD to progress faster and with greater
                                                be fostered into a biotech startup, and                    Are you a biomedical scientist who                  fidelity, entering this Challenge is
                                                that eventually any newly created                       believes that he/she has a research idea               appropriate.
                                                startups will contribute to the pool of                 for a biotech start-up? This Challenge is                 Rules for Participating in the
                                                innovative small business companies                     unique because NIDA intends to fund                    Challenge. The Challenge is open to any
                                                that can successfully compete for                       the ‘‘would be’’ startup Founders much                 Founder 18 years of age or older. No
                                                NIDA’s Small Business Innovation                        earlier than most investors, incubators,               prior startup experience is necessary. A


                                           VerDate Sep<11>2014   20:48 Jun 10, 2016   Jkt 238001   PO 00000   Frm 00067   Fmt 4703   Sfmt 4703   E:\FR\FM\13JNN1.SGM   13JNN1



Document Created: 2018-02-08 07:39:35
Document Modified: 2018-02-08 07:39:35
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 15, 2016.
FR Citation81 FR 38192 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR